Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8671 |
High Similarity |
NPD6959 |
Discontinued |
0.8421 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8322 |
Intermediate Similarity |
NPD5405 |
Approved |
0.8322 |
Intermediate Similarity |
NPD5406 |
Approved |
0.8322 |
Intermediate Similarity |
NPD5404 |
Approved |
0.8322 |
Intermediate Similarity |
NPD5408 |
Approved |
0.8255 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8129 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.807 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.8061 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7977 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7917 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7904 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7898 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7898 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7898 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7853 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7812 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7755 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7742 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7724 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7702 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7688 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7688 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7677 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7643 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7643 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7632 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7622 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7598 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7598 |
Intermediate Similarity |
NPD6534 |
Approved |
0.759 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7569 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3764 |
Approved |
0.75 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7455 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7447 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7444 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7444 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7444 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7419 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7412 |
Intermediate Similarity |
NPD5710 |
Approved |
0.741 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7399 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7391 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7378 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7366 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7366 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7366 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7358 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7342 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7341 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.733 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7326 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7326 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7325 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7321 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7314 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7301 |
Intermediate Similarity |
NPD1512 |
Approved |
0.729 |
Intermediate Similarity |
NPD943 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1164 |
Approved |
0.717 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD2309 |
Approved |
0.716 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7128 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7117 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7098 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7091 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7075 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7059 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD920 |
Approved |
0.7048 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7047 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7047 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7045 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.702 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD1283 |
Approved |
0.6987 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD3972 |
Approved |
0.6959 |
Remote Similarity |
NPD9493 |
Approved |
0.6952 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD919 |
Approved |
0.6935 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6935 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD5401 |
Approved |
0.6927 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6914 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6909 |
Remote Similarity |
NPD7236 |
Approved |
0.6902 |
Remote Similarity |
NPD4287 |
Approved |
0.6894 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6894 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6894 |
Remote Similarity |
NPD3299 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.6887 |
Remote Similarity |
NPD3019 |
Approved |
0.6887 |
Remote Similarity |
NPD2932 |
Approved |
0.6875 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6867 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD8438 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD1247 |
Approved |
0.6855 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6854 |
Remote Similarity |
NPD7228 |
Approved |
0.6852 |
Remote Similarity |
NPD2438 |
Suspended |
0.6848 |
Remote Similarity |
NPD6190 |
Approved |
0.6848 |
Remote Similarity |
NPD3295 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6842 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD37 |
Approved |
0.6839 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6839 |
Remote Similarity |
NPD1203 |
Approved |
0.6835 |
Remote Similarity |
NPD3268 |
Approved |
0.6835 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6835 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6829 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD4965 |
Approved |
0.6821 |
Remote Similarity |
NPD4966 |
Approved |
0.6821 |
Remote Similarity |
NPD4967 |
Phase 2 |
0.6816 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6815 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.681
|
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |